GenVec, Inc. (NASDAQ:GNVC)

CAPS Rating: 4 out of 5

A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.

Recs

0
Player Avatar portefeuille (99.75) Submitted: 12/15/2011 11:16:34 PM : Outperform Start Price: $2.71 GNVC Score: -13.61

There are currently 2300 GNVC shares in my "fund" with break-even of around 3.06 USD. http://caps.fool.com/Blogs/fund-trades/678775.

Report this Post Reply

Featured Broker Partners


Advertisement